Informations:
Erreur:
ID
18307
Description
Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT00114764
Lien
https://clinicaltrials.gov/show/NCT00114764
Mots-clés
Versions (1)
- 29/10/2016 29/10/2016 -
Téléchargé le
29 octobre 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Myeloid Leukemia NCT00114764
Eligibility Myeloid Leukemia NCT00114764
- StudyEvent: Eligibility
Similar models
Eligibility Myeloid Leukemia NCT00114764
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Acute Myelocytic Leukemia de novo | Hematological Disease antecedent Absent | Prior Chemotherapy | prior radiation therapy
Item
histologically confirmed de novo aml as evidenced by absence of an antecedent hematologic disease of > 1 months duration, prior chemotherapy, prior radiation therapy or myelodysplastic cytogenetics (as per exclusion criteria)
boolean
C0023467 (UMLS CUI [1,1])
C1515568 (UMLS CUI [1,2])
C0018939 (UMLS CUI [2,1])
C0683336 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C1514457 (UMLS CUI [3])
C0279134 (UMLS CUI [4])
C1515568 (UMLS CUI [1,2])
C0018939 (UMLS CUI [2,1])
C0683336 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C1514457 (UMLS CUI [3])
C0279134 (UMLS CUI [4])
Life Expectancy
Item
life expectancy, with treatment, > 3 months
boolean
C0023671 (UMLS CUI [1])
Age
Item
age > 18 years
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0, 1 or 2
boolean
C1520224 (UMLS CUI [1])
organ function | Chemotherapy
Item
adequate organ function to receive protocol specified chemotherapy
boolean
C0678852 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C0392920 (UMLS CUI [2])
Exclusion Criteria
Item
exclusion
boolean
C0680251 (UMLS CUI [1])
Leukemia, Myeloid, Chronic-Phase | Lymphocyte Activation
Item
subjects in blast transformation of chronic myeloid leukaemia (cml)
boolean
C0023474 (UMLS CUI [1])
C0024262 (UMLS CUI [2])
C0024262 (UMLS CUI [2])
secondary acute myeloid leukemia | Prior Chemotherapy | prior radiation therapy
Item
patients with secondary aml (received previous chemotherapy or radiotherapy)
boolean
C0280449 (UMLS CUI [1])
C1514457 (UMLS CUI [2])
C0279134 (UMLS CUI [3])
C1514457 (UMLS CUI [2])
C0279134 (UMLS CUI [3])
Prior Therapy Acute Myelocytic Leukemia
Item
previous treatment for aml
boolean
C1514463 (UMLS CUI [1,1])
C0023467 (UMLS CUI [1,2])
C0023467 (UMLS CUI [1,2])
Acute Promyelocytic Leukemia | Acute Megakaryocytic Leukemias
Item
patients with aml fab type m3 (acute promyelocytic leukemia, apl) or m7
boolean
C0023487 (UMLS CUI [1])
C0023462 (UMLS CUI [2])
C0023462 (UMLS CUI [2])
Cytogenetic Analysis High risk | Loss of Chromosome 5q | Loss of Chromosome 7q | t(8;21) | Loss of Chromosome 9q | Complex Karyotype | t(9;22) | Chromosome Aberrations Quantity
Item
high risk (unfavourable) cytogenetics [(-5/del(5q), -7/del(7q), t(8;21) with del (9q) or complex karyotype, inv(3q), abn 11q23, 20q, 21q, del(9q), t(6;9), t(9;22), abn 17p, complex karyotypes(>3 abnormalities)]
boolean
C0752095 (UMLS CUI [1,1])
C0332167 (UMLS CUI [1,2])
C1521461 (UMLS CUI [2])
C1517990 (UMLS CUI [3])
C3897139 (UMLS CUI [4])
C1517995 (UMLS CUI [5])
C3273253 (UMLS CUI [6])
C3897138 (UMLS CUI [7])
C0008625 (UMLS CUI [8,1])
C1265611 (UMLS CUI [8,2])
C0332167 (UMLS CUI [1,2])
C1521461 (UMLS CUI [2])
C1517990 (UMLS CUI [3])
C3897139 (UMLS CUI [4])
C1517995 (UMLS CUI [5])
C3273253 (UMLS CUI [6])
C3897138 (UMLS CUI [7])
C0008625 (UMLS CUI [8,1])
C1265611 (UMLS CUI [8,2])